What Underlies the Benefit of Famotidine Formulations Used During COVID-19?

Document Details

Document Type
Pub Defense Publication
Publication Date
Apr 01, 2021
Source ID
10.1053/j.gastro.2020.07.051

Entities

People

  • Bara El-kurdi
  • Christopher Rood
  • Vijay P Singh

Organizations

  • National Institute of Diabetes and Digestive and Kidney Diseases
  • United States Department of Defense